SaaS platform using NLP to match patients with clinical trials. Reduces recruitment costs by 40% and time by 70%. Targets $45B clinical trials market with tiered enterprise pricing.
TrialMatch addresses the critical bottleneck in clinical research: patient recruitment. By leveraging advanced natural language processing to analyze electronic health records, our platform automatically identifies eligible patients for ongoing trials, reducing recruitment time from months to weeks while cutting pharmaceutical companies’ costs by 40%. This AI-driven solution serves a $45 billion global market struggling with inefficient manual screening processes.
Core Functionality
TrialMatch operates as a HIPAA-compliant SaaS platform that integrates with hospital EHR systems through FHIR APIs. The core AI engine uses spaCy and custom NLP models to analyze unstructured medical records, extracting relevant clinical data and matching patient profiles against trial eligibility criteria. The system features:
- Automated eligibility screening with 95% accuracy
- Real-time recruitment analytics dashboard
- Secure patient notification system
- Trial feasibility analysis for sponsors
- Comprehensive audit trails for regulatory compliance
Target User and Segment
We target three primary segments:
- Enterprise: Top 20 pharmaceutical companies (€75K/year)
- Mid-market: Contract research organizations (€35K/year)
- SMB: Research hospitals and academic centers (€15K/year)
Primary users are clinical trial managers and patient recruitment specialists who currently spend 30-40% of their time on manual patient screening.
Recommended Tech Stack
- Backend: Python/Django with RESTful APIs
- Frontend: React with TypeScript
- Database: PostgreSQL with encrypted storage
- NLP Engine: spaCy/NLTK with custom models
- Infrastructure: AWS with HIPAA-compliant architecture
- Integration: FHIR APIs for EHR connectivity
Estimated MVP Hours and Costs
Development at €100/hour:
- Backend development: 400 hours (€40,000)
- Frontend development: 300 hours (€30,000)
- NLP engine development: 350 hours (€35,000)
- Security & compliance: 200 hours (€20,000)
- Total MVP cost: 1,250 hours (€125,000)
SWOT Analysis
| Strengths | Weaknesses |
|---|---|
| 70% faster recruitment | High regulatory requirements |
| 40% cost reduction | EHR integration dependency |
| Proprietary matching algorithm | Long sales cycles |
| Opportunities | Threats |
| $45B growing market | Established competitors |
| Increasing trial complexity | Regulatory changes |
| Rare disease focus | Data privacy concerns |
First 1000 Customers Strategy
Acquisition Channels:
- Direct sales to top 20 pharma companies (€15K CAC)
- Bio-IT World and SCOPE Summit conferences
- CRO partnerships with commission structure
- Whitepapers on recruitment efficiency metrics
Expected Conversions: 3% enterprise conversion rate with 12-month sales cycle. €250,000 acquisition budget for Year 1 targeting 100 initial clients.
Monetization
Business Model: Tiered SaaS subscription + implementation fees
Pricing:
- Enterprise: €75,000/year (unlimited trials)
- Mid-market: €35,000/year (25 trials)
- SMB: €15,000/year (10 trials)
Break-even: Requires 17 enterprise clients or equivalent mix to cover €1.2M annual operating costs
Core Personnel: Year 1: CEO, CTO, 2 developers, compliance officer (€450K burn). Year 2: Add 3 sales reps and 2 customer success managers.
Market Positioning and Competitors
Regional Markets: North America ($18B), Europe ($12B), Asia-Pacific ($9B) clinical trial services
Competitors: Antidote Technologies, Deep 6 AI, TriNetX – but we differentiate through superior NLP accuracy (95% vs industry average 82%) and real-time analytics
Sales Strategy: Land-and-expand with enterprise pharma, partner with CROs for smaller biotechs
Market Niche: Focus on oncology and rare disease trials where patient recruitment is most challenging and valuable
